AI assistant
Aggreko Plc — Director's Dealing 2020
Mar 12, 2020
74738_rns_2020-03-12_d1b36718-6420-406e-8454-c695463fd520.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 9772F
Aggreko PLC
12 March 2020
12 March 2020
NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES
The notification made on behalf of Persons Discharging Managerial Responsibility ('PDMRs') under article 19.1 of the Market Abuse Regulation ('MAR') relates to transactions made on behalf of Sarah Kuijlaars, a PDMR, in Aggreko plc shares.
This announcement is made in accordance with Article 19.3 of MAR
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Sarah Mary Kuijlaars
2
Reason for the notification
a)
Position/status
Non-Executive Director
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Aggreko plc
b)
LEI
2138003R7TGCSVF27H47
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 4 329/395 pence each ('Shares')
GB00BK1PTB77
b)
Nature of the transaction
Purchase of Shares
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £5.10796 | 3,000 |
d)
Aggregated information
- Aggregated volume
- Total
3,000
£15,323.88
e)
Date of the transaction
12 March 2020
f)
Place of the transaction
London Stock Exchange, XLON
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHGZGMFKZLGGZM